https://scholars.lib.ntu.edu.tw/handle/123456789/597070| Title: | Matching-adjusted indirect comparison of ribociclib plus fulvestrant versus palbociclib plus letrozole as first-line treatment of hr+/her2? advanced breast cancer | Authors: | Fasching P.A. Delea T.E. YEN-SHEN LU De Boer R. Hurvitz S.A. Moynahan A. Chandiwana D. Lanoue B. Hu H. Thuerigen A. O��shaughnessy J. |
Issue Date: | 2021 | Publisher: | Dove Medical Press Ltd | Journal Volume: | 13 | Start page/Pages: | 8179-8189 | Source: | Cancer Management and Research | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121039413&doi=10.2147%2fCMAR.S325043&partnerID=40&md5=9c5ed97c0a25948ee637509170f20240 https://scholars.lib.ntu.edu.tw/handle/123456789/597070 |
ISSN: | 1179-1322 | DOI: | 10.2147/CMAR.S325043 | SDG/Keyword: | [SDGs]SDG3 |
| Appears in Collections: | 醫學院附設醫院 (臺大醫院) |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
